NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
15.41
-0.61 (-3.81%)
Nov 16, 2026, 4:00 PM EST - Market closed

NeoGenomics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
787.75727.33660.57591.64509.73484.33
Revenue Growth
11.08%10.11%11.65%16.07%5.24%8.97%
Cost of Revenue
435.08413.44370.47347.04321.83297.27
Gross Profit
352.67313.89290.1244.6187.9187.06
Selling, General & Admin
356.47346.46330.04313.94310.68283.94
Research & Development
39.3337.0831.1627.3130.3321.87
Operating Expenses
395.8383.54361.2341.25341305.81
Operating Income
-43.13-69.65-71.1-96.65-153.11-118.75
Interest Expense
-3.25-3.75-6.62-6.91-7.58-8.22
Interest & Investment Income
5.219.0718.4316.96.08112.4
Other Non Operating Income (Expenses)
0.050.3-0.380.64-0.21-0.5
EBT Excluding Unusual Items
-41.12-64.03-59.66-86.01-154.83-15.08
Merger & Restructuring Charges
-4.7-4.7-6.66-11.09-4.52-
Impairment of Goodwill
--3.5----
Asset Writedown
-0.63-23.85----
Legal Settlements
-0.41-11.28-13.75---
Other Unusual Items
10.68-2.9-0.6---
Pretax Income
-36.18-110.27-80.68-97.1-159.34-15.08
Income Tax Expense
-3.88-2.24-1.95-9.13-15.09-6.73
Net Income
-32.3-108.03-78.73-87.97-144.25-8.35
Net Income to Common
-32.3-108.03-78.73-87.97-144.25-8.35
Net Income Growth
------
Shares Outstanding (Basic)
129128127126124120
Shares Outstanding (Diluted)
129128127126124120
Shares Change
1.00%1.14%0.92%1.03%3.55%7.31%
EPS (Basic)
-0.25-0.84-0.62-0.70-1.16-0.07
EPS (Diluted)
-0.25-0.84-0.62-0.70-1.16-0.07
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-28.58-21.78-34.04-30.71-96.88-90.87
Free Cash Flow Per Share
-0.22-0.17-0.27-0.24-0.78-0.76
Gross Margin
44.77%43.16%43.92%41.34%36.86%38.62%
Operating Margin
-5.47%-9.57%-10.76%-16.34%-30.04%-24.52%
Profit Margin
-4.10%-14.85%-11.92%-14.87%-28.30%-1.72%
Free Cash Flow Margin
-3.63%-2.99%-5.15%-5.19%-19.01%-18.76%
EBITDA
22.76-1.821.45-24.07-83.68-65.4
EBITDA Margin
2.89%-0.25%0.22%-4.07%-16.42%-13.50%
D&A For EBITDA
65.8967.8272.5572.5869.4353.35
EBIT
-43.13-69.65-71.1-96.65-153.11-118.75
EBIT Margin
-5.47%-9.57%-10.76%-16.34%-30.04%-24.52%
Revenue as Reported
-----484.33
SEC Filings: 10-K · 10-Q